Compare SoundHound AI Inc (SOUN) vs BIO-TECHNE Corp (TECH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SoundHound AI Inc vs BIO-TECHNE Corp — how do they compare? SoundHound AI Inc trades at $7.42 (market cap $3.25B), while BIO-TECHNE Corp trades at $72.13 (market cap $11.24B). The key difference: BIO-TECHNE Corp is far larger — about 3.5× SoundHound AI Inc's market cap, and BIO-TECHNE Corp pays a 0.44% dividend while SoundHound AI Inc pays none. Which is the better fit depends on your goals.
| SOUN | TECH | |
|---|---|---|
Market Cap | $3.25B | $11.24B |
Sector | Technology | Health |
52-Week High | $21.40 | $72.29 |
52-Week Low | $5.70 | $43.31 |
Enterprise Value | $3.05B | $11.32B |
Dividend Yield | — | 0.44% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SoundHound AI (SOUN) trades at $8.02, up 13.28% today, showing strong momentum after beating Q2 2026 earnings expectations. The stock maintains a bullish technical signal with support at $7 and resistance at $9. Revenue grew 45% last quarter to $61.9M, though the company remains unprofitable with a -67.45% net margin. Analyst consensus is strongly bullish with 75% buy ratings and an $8.50 price target.
SOUN offers growth potential through its OASYS platform expansion and enterprise adoption, but faces significant execution risks from persistent losses, cash burn, and premium valuation. The stock's near-term trajectory depends on continued revenue acceleration and path to profitability. High valuation multiples and negative cash flow present challenges despite strong analyst support.
Bio-Techne (TECH) trades at $72.29, up 0.54% today, with a bullish technical signal from moving averages and a consensus analyst price target of $71.67. Recent earnings showed mixed results, with a Q4 2025 beat but a Q1 2026 miss. The company maintains strong gross margins at 64.96% but faces declining net income margins, down to 6.01% in 2025. Positive cash flow trends and a pending acquisition by Merck highlight ongoing corporate developments.
Outlook is balanced with growth potential from product innovation and acquisition synergies, but risks include earnings volatility, high valuation multiples, and shareholder litigation over the merger terms. Institutional sentiment is split evenly between buy and hold ratings, reflecting cautious optimism amid execution challenges.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SoundHound AI Inc
SoundHound AI, Inc. is a leading innovator in voice artificial intelligence, specializing in conversational intelligence technology. The company develops a platform that allows businesses to add custom voice assistants and natural language processing capabilities to their products and services, ranging from in-car systems and smart speakers to mobile apps and IoT devices. SoundHound's core technology, including its proprietary speech recognition and natural language understanding models, aims to enable fast, accurate, and deeply integrated voice AI experiences across various industries.
Read more on SOUN →About BIO-TECHNE Corp
Based in Minnesota, Bio-Techne is a life sciences manufacturer supplying consumables and instruments for the pharma, biotech, academic, and diagnostic markets. The company reports in two segments, protein sciences (75% of revenue), and diagnostics and genomics (25%). The protein-focused segment makes equipment and associated consumables for protein characterization and analysis and sells antibodies for research and clinical purposes. In diagnostics, Bio-Techne provides controls and calibrators for diagnostic manufacturers and has a portfolio of diagnostic oncology assays. The United States accounts for about 55% of revenue, and the firm also has operations in EMEA (20% of sales), the U.K. (5%), and APAC (15%), with the rest of the world accounting for the remaining 5%.
Read more on TECH →
